Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
  • Alerts
  • Podcasts
  • Subscriptions

The “one airway, one disease” concept in light of Th2 inflammation

Lisa Giovannini-Chami, Agnès Paquet, Céline Sanfiorenzo, Nicolas Pons, Julie Cazareth, Virginie Magnone, Kévin Lebrigand, Benoit Chevalier, Ambre Vallauri, Valérie Julia, Charles-Hugo Marquette, Brice Marcet, Sylvie Leroy, Pascal Barbry
European Respiratory Journal 2018; DOI: 10.1183/13993003.00437-2018
Lisa Giovannini-Chami
Université Côte d'Azur, Hôpitaux pédiatriques de Nice CHU-Lenval, Pediatric Pulmonology and Allergology Department, Nice, FranceUniversité Côte d'Azur, CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, Sophia Antipolis, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Agnès Paquet
Université Côte d'Azur, CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, Sophia Antipolis, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Céline Sanfiorenzo
Université Côte d'Azur, CHU de Nice, FHU Oncoage, Pulmonology Department, Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas Pons
Université Côte d'Azur, CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, Sophia Antipolis, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie Cazareth
Université Côte d'Azur, CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, Sophia Antipolis, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Virginie Magnone
Université Côte d'Azur, CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, Sophia Antipolis, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kévin Lebrigand
Université Côte d'Azur, CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, Sophia Antipolis, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benoit Chevalier
Université Côte d'Azur, CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, Sophia Antipolis, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ambre Vallauri
Université Côte d'Azur, CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, Sophia Antipolis, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valérie Julia
Université Côte d'Azur, CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, Sophia Antipolis, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles-Hugo Marquette
Université Côte d'Azur, CHU de Nice, FHU Oncoage, Pulmonology Department, Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brice Marcet
Université Côte d'Azur, CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, Sophia Antipolis, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sylvie Leroy
Université Côte d'Azur, CHU de Nice, FHU Oncoage, Pulmonology Department, Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pascal Barbry
Université Côte d'Azur, CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, Sophia Antipolis, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pascal Barbry
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1183/13993003.00437-2018
PubMed 
30190271

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Published online September 6, 2018.

Article Versions

  • You are currently viewing a previous version of this article (September 6, 2018 - 04:51).
  • View the most recent version of this article
Copyright & Usage 
Copyright ©ERS 2018

Author Information

  1. Lisa Giovannini-Chami1,2,*,
  2. Agnès Paquet2,*,
  3. Céline Sanfiorenzo3,
  4. Nicolas Pons2,
  5. Julie Cazareth2,
  6. Virginie Magnone2,
  7. Kévin Lebrigand2,
  8. Benoit Chevalier2,
  9. Ambre Vallauri2,
  10. Valérie Julia2,
  11. Charles-Hugo Marquette3,
  12. Brice Marcet2,
  13. Sylvie Leroy3,$ and
  14. Pascal Barbry2,$
  1. 1Université Côte d'Azur, Hôpitaux pédiatriques de Nice CHU-Lenval, Pediatric Pulmonology and Allergology Department, Nice, France
  2. 2Université Côte d'Azur, CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, Sophia Antipolis, France
  3. 3Université Côte d'Azur, CHU de Nice, FHU Oncoage, Pulmonology Department, Nice, France
  1. Dr Lisa Giovannini-Chami, Pediatric Pneumology and Allergology Department, Hôpitaux pédiatriques de Nice CHU-Lenval, 57 avenue de la Californie, 06200 NICE, France. E-mail: giovannini-chami.l{at}pediatrie-chulenval-nice.fr
  1. ↵*,$ These authors contributed equally to this work

View Full Text

Funding

  • Fondation pour la Recherche Médicale

    DEQ20180339158
  • Agence Nationale de la Recherche

    ANR-10-INBS-09-02; ANR-10-INBS-09-03; ANR-12-BSV1-0023
  • “Fond de recherche en santé respiratoire” ARARD (2013)

  • Association RESPIR

Article usage

Article usage: September 2018 to November 2019

AbstractFullPdf
Sep 201875411960
Oct 201854814481
Nov 2018864272129
Dec 20184773728
Jan 20193323620
Feb 2019951212
Mar 20191341917
Apr 201967116
May 20198779
Jun 20191141211
Jul 2019671912
Aug 20197154
Sep 2019761112
Oct 201980125
Nov 2019921011

Altmetrics

PreviousNext
Back to top
View this article with LENS
Vol 54 Issue 6 Table of Contents
European Respiratory Journal: 54 (6)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The “one airway, one disease” concept in light of Th2 inflammation
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
The “one airway, one disease” concept in light of Th2 inflammation
Lisa Giovannini-Chami, Agnès Paquet, Céline Sanfiorenzo, Nicolas Pons, Julie Cazareth, Virginie Magnone, Kévin Lebrigand, Benoit Chevalier, Ambre Vallauri, Valérie Julia, Charles-Hugo Marquette, Brice Marcet, Sylvie Leroy, Pascal Barbry
European Respiratory Journal Jan 2018, 1800437; DOI: 10.1183/13993003.00437-2018

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
The “one airway, one disease” concept in light of Th2 inflammation
Lisa Giovannini-Chami, Agnès Paquet, Céline Sanfiorenzo, Nicolas Pons, Julie Cazareth, Virginie Magnone, Kévin Lebrigand, Benoit Chevalier, Ambre Vallauri, Valérie Julia, Charles-Hugo Marquette, Brice Marcet, Sylvie Leroy, Pascal Barbry
European Respiratory Journal Jan 2018, 1800437; DOI: 10.1183/13993003.00437-2018
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
  • Info & Metrics
  • PDF

Subjects

  • Lung biology and experimental studies
  • Asthma and allergy
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Targeting Treatable Traits in Severe Asthma: A Randomised Controlled Trial
  • Morphomolecular motifs of pulmonary neoangiogenesis in interstitial lung diseases
  • Acute air pollution exposure alters neutrophils in never-smokers and at-risk humans
Show more Original article

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Collections
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2019 by the European Respiratory Society